Hadassah En Karem Medical Center

Jerusalem 9112001

0 studies enrolling now · 2 studies all time

What they study most

Mantle Cell Lymphoma, Marginal Zone Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma — Running, not enrolling